The most commonly used beta-lactam antibiotics for the therapy of infe
ctious diseases are penicillin and cephalosporin. Penicillin is produc
ed as an end product by some fungi, most notably by Aspergillus (Emeri
cella) nidulans and Penicillium chrysogenum. Cephalosporins are synthe
sized by both bacteria and fungi, e.g., by the fungus Acremonium chrys
ogenum (Cephalosporium acremonium). The biosynthetic pathways leading
to both secondary metabolites start from the same three amino acid pre
cursors and have the first two enzymatic reactions in common. Penicill
in biosynthesis is catalyzed by three enzymes encoded by acvA (pcbAB)
ipnA (pcbC), and aatA (penDE). The genes are organized into a cluster.
In A. chrysogenum, in addition to acvA and ipnA, a second cluster con
tains the genes encoding enzymes that catalyze the reactions of the la
ter steps of the the cephalosporin pathway (cefEF and cefG). Within th
e last few years, several studies have indicated that the fungal beta-
lactam biosynthesis genes are controlled by a complex regulatory netwo
rk, e.g., by the ambient pH, carbon source, and amino acids. A compari
son with the regulatory mechanisms (regulatory proteins and DNA elemen
ts) involved in the regulation of genes of primary metabolism in lower
eukaryotes is thus of great interest. This has already led to the elu
cidation of new regulatory mechanisms. Furthermore, such investigation
s have contributed to the elucidation of signals leading to the produc
tion of beta-lactams and their physiological meaning for the producing
fungi, and they can be expected to have a major impact on rational st
rain improvement programs. The knowledge of biosynthesis genes has alr
eady been used to produce new compounds.